NHS
UK budget sees R&D tax credits rise
December 3, 2014Sales and Marketing Budget, Cameron, George Osborne, NHS, Whitehead, life sciences
Chancellor George Osborne has delivered the government’s 2014 Autumn Statement to the Commons which includes news of an increase in …
Hunt sets out plans for expanded NHS budget
December 3, 2014Sales and Marketing Budget, Hunt, NHS, UK, election, health, king's fund
Health secretary Jeremy Hunt has laid out his plans for the future of the NHS in a speech to parliament, …
NICE U-turn on Roche leukaemia drug
December 2, 2014Sales and Marketing Gazyvaro, MabThera, NHS, NICE, Roche, leukaemia, obinutuzumab
NICE has reversed its decision on Roche’s chronic lymphocytic leukaemia (CLL) drug Gazyvaro only two months after rejecting the drug. …
£2 billion government plan to ‘save the NHS’
December 1, 2014Sales and Marketing Conservatives, NHS, Osborne, UK, balls, election, spending
George Osborne in his Autumn Statement on Wednesday will announce an extra £2 billion funding for the NHS in an attempt …
George Freeman: UK pharma is vital for our landscape
December 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, WHO, freeman, medicine, stratified
The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …
Lundbeck’s alcohol pill given NICE approval
November 27, 2014Sales and Marketing Lundbeck, NHS, NICE, alcohol, selincro
NICE has finally approved the use of Selincro (nalmefene) in order to help people who are dependent on alcohol cut …
NHS needs £2 billion more in funding
November 26, 2014Medical Communications, Sales and Marketing Cameron, Hunt, Kings Fund, NHS, Osborne, king's fund, statement
Healthcare think tank the King’s Fund has called for an additional £2 billion to be injected into the NHS in …
UK lags behind in healthcare outcomes index
November 26, 2014Research and Development, Sales and Marketing Japan, NHS, UK, WHO, economist, health outcomes
Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …
ABPI: NHS must change to allow stratified drugs
November 21, 2014Research and Development, Sales and Marketing ABPI, NHS, george freeman, personalised, rawal, stratified medicines
The development of stratified medicines – especially in therapy areas outside of oncology – will have a significant effect on …
NICE aims for earlier cancer diagnosis
November 20, 2014Sales and Marketing Cancer, England, NHS, NICE, OECD, UK, baker
NICE is updating its guidance in a bid to help doctors spot the signs and symptoms of cancer as part …
NICE wants more Xolair data
November 19, 2014Sales and Marketing Genentech, NHS, NICE, Novartis, UK, Xolair, hives, omalizumab
Novartis has been asked in draft guidance to give NICE more information before the watchdog can recommend its veteran asthma …
Hunt unveils £10 billion NHS savings plan
November 14, 2014Sales and Marketing Cameron, HSCIC, Hunt, Labour, NHS, burnham, digital, savings
Health secretary Jeremy Hunt has laid out efficiency plans that he hopes will save the NHS up to £10 billion …
Cost of NHS medicines rises
November 14, 2014Sales and Marketing HSCIC, NHS, NICE, PPRS, drugs, hospitals, spend
Hospitals in England are taking an increasing share of the NHS’s bill for drugs approved by NICE, according to a …
NHS to ‘kitemark’ health-related apps
November 13, 2014Medical Communications, Sales and Marketing Apple, Hunt, NHS, Samsung, apps, kitemark, wearables
Plans to improve the quality of patient care by introducing a ‘kitemark’ to safely validate healthcare apps have been announced …
Charity ‘deeply concerned’ on CDF changes
November 13, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, breakthrough breast cancer, palframan
A leading cancer charity has warned that a number of key drugs are at risk of being withdrawn from patients …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
